Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats

Journal of Neurochemistry

Volumn 96, Issue 6, 2006, Pages 1718-1727

  Carta, Manolo ^a,b   Lindgren, Hanna S ^a   Lundblad, Martin ^a   Stancampiano, Roberto ^b   Fadda, Fabio ^b   Cenci, M A ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

5 HT; Dyskinesia; Microdialysis; Parkinson's disease; Striatum

Indexed keywords

LEVODOPA; OXIDOPAMINE; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DRUG BIOAVAILABILITY; DRUG SENSITIVITY; DYSKINESIA; EXTRACELLULAR FLUID; FEMALE; MOTOR DYSFUNCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STEADY STATE; STRIATE CORTEX; TISSUE LEVEL;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; EXTRACELLULAR FLUID; FEMALE; LEVODOPA; MICRODIALYSIS; MICROINJECTIONS; NEURAL PATHWAYS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; UP-REGULATION;

ANIMALIA;

EID: 33644813224     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03696.x     Document Type: Article

References (30)

1. Ahn S. Cheng C. Phillips AG. Lee CS. 2004 Reversal of the dopamine transporter in the severely 6-OHDA lesioned striatum with chronic l -DOPA treatment: a Reverse Dialysis Study with GBR 12909 SocNeurosciAbstrView 562.3q13.
2. Andersson M. Hilbertson A. Cenci MA. 1999 Striatal fosB expression is causally linked with l -DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease NeurobiolDis 6 461 474
3. 1 dopamine receptor signaling in levodopa-induced dyskinesia AnnNeurol 57 17 26
4. Cenci MA. 2002 Transcription factors involved in the pathogenesis of l -DOPA-induced dyskinesia in a rat model of Parkinson's disease Amino Acids 23 105 109
5. Cenci MA. Lee CS. Bjorklund A. 1998 l -DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin and glutamic acid decarboxylase mRNA EurJNeurosci 10 2694 2706
6. Cenci MA. Whishaw IQ. Schallert T. 2002 Animal models of neurological deficits: how relevant is the rat? NatRevNeurosci 3 574 579
7. Chase TN. 1998 Levodopa therapy: consequences of the non-physiologic replacement of dopamine Neurology 50 S17 S25
8. Contin M. Riva R. Martinelli P. Cortelli P. Albani F. Baruzzi A. 1993 Pharmacodynamic modeling of oral levodopa: clinical application in Parkinson's disease Neurology 43 367 371
9. Fahn S. 2000 The spectrum of levodopa-induced dyskinesias AnnNeurol 47 S2 S11
10. de la Fuente-Fernandez R. Sossi V. Huang Z. Furtado S. Lu JQ. Calne DB. Ruth TJ. Stoessl AJ. 2004 Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias Brain 127 2747 2754
11. Horne MK. Cheng CH. Wooten GF. 1984 The cerebral metabolism of 1-dihydroxyphenylalanine. An autoradiographic and biochemical study Pharmacology 28 12 26
12. Igarashi K. Hotta K. Kasuya F. Abe K. Sakoda S. 2003 Determination of cabergoline and l -dopa in human plasma using liquid chromatography-tandem mass spectrometry JChromatogrB AnalTechnolBiomedLife Sci 792 55 61
13. Jacobs BL. Azmitia EC. 1992 Structure and function of the brain serotonin system PhysiolRev 72 165 229
14. Lopez A. Munoz A. Guerra MJ. Labandeira-Garcia JL. 2001 Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum Neuroscience 103 639 651
15. Lundblad M. Andersson M. Winkler C. Kirik D. Wierup N. Cenci MA. 2002 Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease EurJNeurosci 15 120 132
16. Luquin MR. Scipioni O. Vaamonde J. Gershanik O. Obeso JA. 1992 Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification MovDisord 7 117 124
17. Marsden CD. Parkes JD. Quinn N. 1981 Fluctuations in disability in Parkinson's disease - clinical aspects, in Movement Disorders Marsden CD. Fahn S., eds), pp. 96 122 Butterworths London
18. Melamed E. Hefti F. Pettibone DJ. Liebman J. Wurtman RJ. 1981 Aromatic l -amino acid decarboxylase in rat corpus striatum: implications for action of l -dopa in parkinsonism Neurology 31 651 655
19. Nutt JG. 1992 Dyskinesia induced by levodopa and dopamine agonists in patients with Parkinson's disease, in Drug-Induced Movement Disorders Lang AE. Weiner WJ., eds), pp. 281 314 Futura Publishing Co. Inc. Mount Kisko
20. Obeso JA. Rodriguez-Oroz M. Marin C. Alonso F. Zamarbide I. Lanciego JL. Rodriguez-Diaz M. 2004 The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits Neurology 62 S17 S30
21. Olanow CW. Gauger LL. Cedarbaum JM. 1991 Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease AnnNeurol 29 556 559
22. Papa SM. Engber TM. Kask AM. Chase TN. 1994 Motor fluctuations in levodopa-treated parkinsonian rats: relation to lesion extent and treatment duration Brain Res 662 69 74
23. Pardridge WM. Oldendorf WH. 1975 Kinetic analysis of blood-brain barrier transport of amino acids BiochimBiophysActa 401 128 136
24. Picconi B. Centonze D. Hakansson K. Bernardi G. Greengard P. Fisone G. Cenci MA. Calabresi P. 2003 Loss of bidirectional striatal synaptic plasticity in l -DOPA-induced dyskinesia NatNeurosci 6 501 506
25. Rajput AH. Fenton ME. Di Paolo T. Sitte H. Pifl C. Hornykiewicz O. 2004 Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off Parkinsonism RelatDisord 10 221 226
26. Schmidt RH. Björklund A. Stenevi U. Dunnett SB. Gage FH. 1983 Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism Acta PhysiolScandSuppl 522 19 37
27. Wade LA. Katzman R. 1975a Synthetic amino acids and the nature of l -DOPA transport at the blood-brain barrier JNeurochem 25 837 842
28. Wade LA. Katzman R. 1975b Rat brain regional uptake and decarboxylation of l -DOPA following carotid injection AmJPhysiol 228 352 359
29. Winkler C. Kirik D. Bjorklund A. Cenci MA. 2002 l -DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function NeurobiolDis 10 165 186
30. Zigmond MJ. Abercrombie ED. Berger TW. Grace AA. Stricker EM. 1990 Compensations after lesions of central dopaminergic neurons: some clinical and basic implications Trends Neurosci 13 290 296